Stimuli Technology

Solution for treating patients with overactive bladder

Mission

Raise public awareness of the symptoms of overactive bladder

Stimuli Technology aims to improve the lives of patients with overactive bladder through technology based on transcutaneous electrical nerve stimulation, more commonly called TENS (Transcutaneous Electrical Nerve Stimulation).

To meet this need, Stimuli Technology has developed Tensi+, a medical device treating overactive bladder.

This non-invasive treatment placed on the passage of the posterior tibial nerve sends electrical stimulations via electrodes located on the skin.

Ambition

Improving the lives of patients with overactive bladder

Overactive bladder affects both men and women today and can occur at any age. It manifests itself mainly by the frequent, sudden and uncontrollable urge to urinate; these symptoms can occur at any time of the day or night.

Studies have shown that 15% of the population is affected by overactive bladder, which is currently underdiagnosed.

Now well established in France and recognized by several renowned urology doctors, the Stimuli Technology team is now targeting the European market.

The Team

Stimuli Management team

Delphine Agullo

Présidente

Gaspard Moreau

Responsable Industrialisation

Laure De Martel

Responsable Marketing

Akshaya Mariadassou

Responsable Qualité & Affaires Réglementaires

They talk about it

Testimonials

The Technofounders ecosystem supports me, facilitating the daily management of the company and thus allowing me to concentrate fully on strategic and commercial development. In just 4 months, I was able to carry out an express fundraising campaign, recruit 10 people and launch our medical device on the French market.
Delphine Agullo
CEO - Stimuli Technology

Healthcare

Improving the daily lives of practitioners and the effectiveness of care

Deploy new technological and industrial solutions to healthcare professionals in order to improve the well-being of patients and the daily lives of practitioners.